Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Immunocore $250 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
Tencent €300 million investment in Ubisoft
We are advising Tencent on the transaction
Williams $423 million acquisition of NorTex Midstream Holdings
We advised Williams on the transaction
RXR Realty $1.29 billion refinancing of 5 Times Square
We advised RXR on the refinancing and related joint ventures
Sitio Royalties $4.8 billion all-stock merger with Brigham Minerals
We are advising Sitio Royalties on the transaction
Novo Nordisk $1.1 billion acquisition of Forma Therapeutics
We are advising Novo Nordisk on the transaction
Biocytogen HK$549 million IPO
We advised Biocytogen on its IPO and HKEX listing
Roper Technologies $3.725 billion acquisition of Frontline Education
We are advising Roper on the transaction
Numerix acquisition by GenStar Capital
We advised Numerix on the transaction
Blackstone and CPPIB $1.96 billion Advarra acquisition financing
We advised the lead arrangers and initial term lenders on the financing